Business, energy, technology, markets and global industry news from Business News Today
PharmaDeviceNews
Representative image of a laboratory Alzheimer’s biomarker study, highlighting plasma tau testing and cognitive decline analysis, as C2N Diagnostics advances its PrecivityTauDx programme with Phase 3 evidence for tangle biomarkers.
Medical Devices & Diagnostics

C2N Diagnostics advances PrecivityTauDx programme as tangle biomarker gains Phase 3 evidence

C2N's eMTBR-tau243 plasma assay shows independent prognostic value in Phase 3 Evoke data. What this means for Alzheimer's patient selection. Read the analysis.

Read More
Pharma & Biotech

LGM Pharma’s $15m U.S. manufacturing expansion signals a deeper shift away from import dependence in pharma supply chains

LGM Pharma expands U.S. CDMO capacity with a $15M investment across Texas and Colorado. Explore what this means for domestic drug manufacturing. Read more.

Read More
Representative image of a rapid diagnostic system used in hospital laboratories, reflecting how Pattern Bioscience’s pneumonia ID AST panel aims to deliver faster phenotypic results for critically ill patients and improve antibiotic decision making in ICU settings.
Medical Devices & Diagnostics

Is culture-free pneumonia testing finally viable as Pattern Bioscience nears regulatory submission

Pattern Bioscience advances rapid pneumonia diagnostics toward FDA clearance. Discover what this means for ICU care and antibiotic resistance.

Read More
Pharma & Biotech

Triana Biomedicines tests degradation-first approach in ALK positive lung cancer with TRI-611

Triana Biomedicines launches TRI-611 trial in ALK lung cancer. Can molecular glue degraders overcome resistance? Read the full analysis.

Read More
Representative image of a hypoglossal nerve stimulation implant procedure used in obstructive sleep apnea treatment, reflecting how LivaNova PLC’s aura6000 System FDA approval could expand eligibility beyond traditional PAP therapy patients.
Medical Devices & Diagnostics

LivaNova PLC expands sleep apnea eligibility as aura6000 gains FDA approval without CCC limits

LivaNova PLC secures FDA approval for aura6000. Discover how it could reshape sleep apnea treatment and expand patient eligibility.

Read More
Pharma & Biotech

Gene therapy gains ground in bladder cancer as NCCN strengthens Ferring Pharmaceuticals’ ADSTILADRIN recommendation

ADSTILADRIN gains NCCN upgrade in bladder cancer. Discover what this means for gene therapy adoption, clinical use, and future NMIBC treatment trends.

Read More
Medical Devices & Diagnostics

Ibex–HNL Lab Medicine deal signals shift from digital pathology to embedded AI decision support in U.S. diagnostics

Ibex partners with HNL Lab Medicine to deploy AI in prostate cancer diagnostics. Discover what this means for pathology workflows and adoption.

Read More
Radiotherapy for arthritis moves closer to mainstream as Varian TrueBeam gains new FDA nod
Medical Devices & Diagnostics

Can low-dose radiotherapy reshape osteoarthritis care after Siemens Healthineers’ FDA clearance

Siemens Healthineers expands TrueBeam into osteoarthritis care with FDA clearance. Find out how radiotherapy could reshape chronic pain treatment.

Read More
Pharma & Biotech

Cathy Tie’s Origin Genomics targets germline gene correction under US IRB oversight

Origin Genomics launches in New York to advance germline gene correction and MRT under IRB oversight. Analyse what it means for US gene editing regulation.

Read More
Pharma & Biotech

Oral Pompe therapy S-606001 moves to Phase 2 as Shionogi expands rare disease focus

Shionogi's S-606001 enters global Phase 2 as the first oral GYS1 inhibitor tested as an add-on to ERT in late-onset Pompe disease. Read the analysis.

Read More